Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among individuals with type 2 diabetes (T2D), yet accurate identification from electronic health records (EHRs) remains challenging because clinically relevant information is fragmented across structured data and unstructured clinical documentation. We developed a rule-based computable phenotype (CP) framework that integrates structured EHRs with clinical notes for scalable MASLD identification in patients with T2D. The framework comprises five complementary CP algorithms derived from validated fibrosis indice
Improving MASLD Identification in Patients with T2D: A Computable Phenotype Framework Integrating Structured Data and Clinical Notes
calendar_today
October 2, 2026
person
Chen, Y., Sharma, A., Yang, Q., Chen, Y., Yin, R.
domain
medrxiv